HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety

Am J Nephrol. 2021;52(10-11):894-898. doi: 10.1159/000518073. Epub 2021 Sep 16.

Authors

Simon D Roger¹, Daniel W Coyne²

Affiliations

¹ Department of Renal Medicine, Gosford Hospital, Gosford, New South Wales, Australia.
² Department of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.

PMID: 34535582
DOI: 10.1159/000518073

No abstract available

Publication types

Comment

MeSH terms

Humans
Hypoxia-Inducible Factor-Proline Dioxygenases
Prolyl-Hydroxylase Inhibitors*
Renal Insufficiency, Chronic*

Substances

Prolyl-Hydroxylase Inhibitors
Hypoxia-Inducible Factor-Proline Dioxygenases